Causal association of genetically determined circulating vitamin D metabolites and calcium with multiple sclerosis in participants of European descent
暂无分享,去创建一个
Tao Wang | Zhifa Han | Yan Zhang | Longcai Wang | Haihua Zhang | Haijie Liu | Gui-fang Liu
[1] B. Engelhardt,et al. Full spectrum of vitamin D immunomodulation in multiple sclerosis: mechanisms and therapeutic implications , 2022, Brain communications.
[2] Tejaswini Ashok,et al. Therapeutic Role of Vitamin D in Multiple Sclerosis: An Essentially Contested Concept , 2022, Cureus.
[3] Ren Wang. Mendelian randomization study updates the effect of 25-hydroxyvitamin D levels on the risk of multiple sclerosis , 2022, Journal of translational medicine.
[4] W. Lowe,et al. Maternal and Neonatal 3-epi-25-hydroxyvitamin D Concentration and Factors Influencing Their Concentrations , 2021, Journal of the Endocrine Society.
[5] F. Rivadeneira,et al. The health effects of vitamin D supplementation: evidence from human studies , 2021, Nature Reviews Endocrinology.
[6] Sheyu Li,et al. Genetically predicted lifelong circulating 25(OH)D levels are associated with serum calcium levels and kidney stone risk. , 2021, The Journal of clinical endocrinology and metabolism.
[7] J. Damoiseaux,et al. Vitamin D supplementation in multiple sclerosis: an expert opinion based on the review of current evidence , 2021, Expert review of neurotherapeutics.
[8] P. Munroe,et al. Genetically Determined Serum Calcium Levels and Markers of Ventricular Repolarization , 2021, Circulation. Genomic and precision medicine.
[9] F. Gao,et al. Impact of serum calcium levels on total body bone mineral density: A mendelian randomization study in five age strata. , 2021, Clinical nutrition.
[10] M. Brandi,et al. Hormonal regulation of biomineralization , 2021, Nature Reviews Endocrinology.
[11] J. Richards,et al. The relative contributions of obesity, vitamin D, leptin, and adiponectin to multiple sclerosis risk: A Mendelian randomization mediation analysis , 2021, Multiple sclerosis.
[12] Wei Wang,et al. Relationship between serum nutritional factors and bone mineral density: a Mendelian randomization study. , 2021, The Journal of clinical endocrinology and metabolism.
[13] J. Danesh,et al. The association between circulating 25-hydroxyvitamin D metabolites and type 2 diabetes in European populations: A meta-analysis and Mendelian randomisation analysis , 2020, PLoS medicine.
[14] S. Larsson,et al. An atlas on risk factors for multiple sclerosis: a Mendelian randomization study , 2020, Journal of Neurology.
[15] H. McNulty,et al. Health effects of vitamin and mineral supplements , 2020, BMJ.
[16] J. Linseisen,et al. Role of Vitamin D in Preventing and Treating Selected Extraskeletal Diseases—An Umbrella Review , 2020, Nutrients.
[17] J. Sellner,et al. Vitamin D Supplementation in Multiple Sclerosis: A Critical Analysis of Potentials and Threats , 2020, Nutrients.
[18] C. Robinson-Cohen,et al. Association of Genetic Variants Related to Serum Calcium Levels with Reduced Bone Mineral Density. , 2020, The Journal of clinical endocrinology and metabolism.
[19] F. Paul,et al. Vitamin D and Disease Severity in Multiple Sclerosis—Baseline Data From the Randomized Controlled Trial (EVIDIMS) , 2020, Frontiers in Neurology.
[20] James R. Staley,et al. A robust and efficient method for Mendelian randomization with hundreds of genetic variants , 2020, Nature Communications.
[21] G. Giovannoni,et al. BMI and low vitamin D are causal factors for multiple sclerosis , 2020, Neurology: Neuroimmunology & Neuroinflammation.
[22] F. Paul,et al. High-dose vitamin D supplementation in multiple sclerosis – results from the randomized EVIDIMS (efficacy of vitamin D supplementation in multiple sclerosis) trial , 2020, Multiple sclerosis journal - experimental, translational and clinical.
[23] P. Visscher,et al. Genome-wide association study identifies 143 loci associated with 25 hydroxyvitamin D concentration , 2019, bioRxiv.
[24] E. Bisson,et al. Multiple sclerosis is associated with low bone mineral density and osteoporosis. , 2019, Neurology. Clinical practice.
[25] Simon C. Potter,et al. Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility , 2019, Science.
[26] S. Larsson,et al. Genetic Prediction of Serum 25-Hydroxyvitamin D, Calcium, and Parathyroid Hormone Levels in Relation to Development of Type 2 Diabetes: A Mendelian Randomization Study , 2019, Diabetes Care.
[27] S. Larsson,et al. Genetic predisposition to increased serum calcium, bone mineral density, and fracture risk in individuals with normal calcium levels: mendelian randomisation study , 2019, BMJ.
[28] Jack Bowden,et al. Meta‐analysis and Mendelian randomization: A review , 2019, Research synthesis methods.
[29] Yang Hu,et al. Circulating vitamin E levels and Alzheimer's disease: a Mendelian randomization study , 2018, Neurobiology of Aging.
[30] J. Danesh,et al. Association of Plasma Vitamin D Metabolites With Incident Type 2 Diabetes: EPIC-InterAct Case-Cohort Study , 2018, The Journal of clinical endocrinology and metabolism.
[31] S. Broadley,et al. Vitamin D for the treatment of multiple sclerosis: a meta-analysis , 2018, Journal of Neurology.
[32] B. Neale,et al. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases , 2018, Nature Genetics.
[33] R. Jorde,et al. C3-epimerization of 25-hydroxyvitamin D increases with increasing serum 25-hydroxyvitamin D levels and shows a high degree of tracking over time. , 2018, Clinical biochemistry.
[34] C. Cooper,et al. Calcium and Vitamin D Supplementation Are Not Associated With Risk of Incident Ischemic Cardiac Events or Death: Findings From the UK Biobank Cohort , 2018, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[35] J. Richards,et al. Mendelian randomization in multiple sclerosis: A causal role for vitamin D and obesity? , 2018, Multiple sclerosis.
[36] A. Ascherio,et al. 25-Hydroxyvitamin D deficiency and risk of MS among women in the Finnish Maternity Cohort , 2017, Neurology.
[37] Stephen Burgess,et al. Association of Genetic Variants Related to Serum Calcium Levels With Coronary Artery Disease and Myocardial Infarction , 2017, JAMA.
[38] S. Thompson,et al. Interpreting findings from Mendelian randomization using the MR-Egger method , 2017, European Journal of Epidemiology.
[39] E. Waubant,et al. Evidence for a causal relationship between low vitamin D, high BMI, and pediatric-onset MS , 2017, Neurology.
[40] Olena O Yavorska,et al. MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data , 2017, International journal of epidemiology.
[41] Sekar Kathiresan,et al. Genetic Association of Waist-to-Hip Ratio With Cardiometabolic Traits, Type 2 Diabetes, and Coronary Heart Disease , 2017, JAMA.
[42] Yongshuai Jiang,et al. Integrating genome-wide association studies and gene expression data highlights dysregulated multiple sclerosis risk pathways , 2017, Multiple sclerosis.
[43] K. Blennow,et al. Calcium supplementation and risk of dementia in women with cerebrovascular disease , 2016, Neurology.
[44] Ba,et al. Mendelian randomization shows a causal effect of low vitamin D on multiple sclerosis risk , 2016, Neurology: Genetics.
[45] David C. Wilson,et al. Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease , 2016, Nature Genetics.
[46] G. Davey Smith,et al. Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator , 2016, Genetic epidemiology.
[47] C. Greenwood,et al. Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study , 2015, PLoS medicine.
[48] D. Nickerson,et al. A Multivariate Genome-Wide Association Analysis of 10 LDL Subfractions, and Their Response to Statin Treatment, in 1868 Caucasians , 2014, bioRxiv.
[49] P. Visscher,et al. Calculating statistical power in Mendelian randomization studies. , 2013, International journal of epidemiology.
[50] Lorna M. Lopez,et al. Meta-Analysis of Genome-Wide Association Studies Identifies Six New Loci for Serum Calcium Concentrations , 2013, PLoS genetics.
[51] G. Hallmans,et al. Vitamin D as a protective factor in multiple sclerosis , 2012, Neurology.
[52] George Davey Smith,et al. Using multiple genetic variants as instrumental variables for modifiable risk factors , 2012, Statistical methods in medical research.
[53] Manolis Kellis,et al. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants , 2011, Nucleic Acids Res..
[54] S. Thompson,et al. Avoiding bias from weak instruments in Mendelian randomization studies. , 2011, International journal of epidemiology.
[55] T. VanderWeele,et al. Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants. , 2011, International journal of epidemiology.
[56] C. Cooper,et al. The Risk of Fracture in Patients With Multiple Sclerosis: The UK General Practice Research Database , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[57] A. Ascherio,et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. , 2006, JAMA.
[58] G. Sigurdsson,et al. Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. , 2005, JAMA.
[59] A. Sadovnick,et al. Vitamin D intake and incidence of multiple sclerosis , 2004, Neurology.
[60] D. Mattson,et al. Sporadic corticosteroid pulses and osteoporosis in multiple sclerosis. , 1996, Archives of neurology.
[61] OUP accepted manuscript , 2021, European Heart Journal.